Tapewire

Nasdaq · USD

ISRG

INTUITIVE SURGICAL INC

Export transactions ↓
Tapewire entity
2878
SEC CIK
0001035267
Parsed reports
1,605

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202507
Jan 202606
Feb 202606
Mar 202609
Apr 202602
May 202606
Jun 202607
Jul 202605
Aug 202609
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 26, 2024 Filed Jan 29, 2024 22:28 UTC
LEVY ALAN JDirector
SaleCommon Stock 72 $370.20 $26,654.57
Disclosure

SEC source: 0001035267-24-000013 · edgardoc.xml · nonDerivative · entry 2

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,319

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.90 to $371.65 as follows: 900 shares sold at $368.90 to $369.78; 600 shares sold at $370.04 to $370.71; and 500 shares sold at $371.60 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:28 UTC
LEVY ALAN JDirector
Exercise / conversionCommon Stock 72 $154.24 $11,105.04
Disclosure

SEC source: 0001035267-24-000013 · edgardoc.xml · nonDerivative · entry 1

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,500 $0.00 Strike: $182.83 $0.00
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · derivative · entry 6

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 1,500 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,818 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · derivative · entry 5

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,893

Underlying: Common Stock · 2,818 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 1,500 $370.15 $555,221.70
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 4

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 1,500 $182.83 $274,249.95
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 2,818 $370.15 $1,043,076.50
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 22:32 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 2,818 $177.99 $501,566.52
Disclosure

SEC source: 0001035267-24-000015 · edgardoc.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 17:56 UTC
Rosa David J.President
GiftCommon Stock 1,572 $0.00 $0.00
Disclosure

SEC source: 0001035267-23-000218 · edgardoc.xml · nonDerivative · entry 1

Rosa David J. · CIK 0001519593 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,140

F1 · kind: The filer gifted shares to Venture Christian Church.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,500 $0.00 Strike: $182.83 $0.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 9

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 1,500 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,819 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 8

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,711

Underlying: Common Stock · 2,819 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,500 $0.00 Strike: $166.62 $0.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · derivative · entry 7

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires 2029-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 1,500 $300.00 $450,000.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 6

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 1,500 $182.83 $274,249.95
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 5

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 4,500 $300.00 $1,350,000.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 4

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 4,500 $166.62 $749,804.85
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 2,819 $300.00 $845,700.00
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:00 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 2,819 $177.99 $501,744.51
Disclosure

SEC source: 0001035267-23-000213 · edgardoc.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 12, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:11 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 9,567 $0.00 Strike: $41.26 $0.00
Disclosure

SEC source: 0001035267-23-000215 · edgardoc.xml · derivative · entry 3

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,567 shares

Expires 2024-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:11 UTC SaleCommon Stock 9,567 $300.00 $2,870,100.00
Disclosure

SEC source: 0001035267-23-000215 · edgardoc.xml · nonDerivative · entry 2

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,706

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 20:11 UTC Exercise / conversionCommon Stock 9,567 $41.26 $394,713.37
Disclosure

SEC source: 0001035267-23-000215 · edgardoc.xml · nonDerivative · entry 1

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,273

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 1, 2024.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:44 UTC
LEVY ALAN JDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $90.49 $0.00
Disclosure

SEC source: 0001035267-23-000210 · edgardoc.xml · derivative · entry 3

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,928

Underlying: Common Stock · 2,000 shares

Expires 2027-04-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:44 UTC
LEVY ALAN JDirector
SaleCommon Stock 2,000 $290.00 $580,000.00
Disclosure

SEC source: 0001035267-23-000210 · edgardoc.xml · nonDerivative · entry 2

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,319

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:44 UTC
LEVY ALAN JDirector
Exercise / conversionCommon Stock 2,000 $90.49 $180,988.80
Disclosure

SEC source: 0001035267-23-000210 · edgardoc.xml · nonDerivative · entry 1

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 597 $0.00 Strike: $245.60 $0.00
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,375

Underlying: Common Stock · 597 shares

Expires 2031-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 270 $0.00 Strike: $242.34 $0.00
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · derivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453

Underlying: Common Stock · 270 shares

Expires 2030-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 270 $290.00 $78,300.00
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,259

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 270 $242.34 $65,430.91
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,529

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 597 $290.00 $173,130.00
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,259

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 23:45 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 597 $245.60 $146,623.20
Disclosure

SEC source: 0001035267-23-000211 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 22:13 UTC GrantRestricted Stock Units · Derivative 240 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-23-000207 · edgardoc.xml · derivative · entry 2

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240

Underlying: Common Stock · 240 shares

Expires not disclosed

F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 22:13 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 722 $0.00 Strike: $277.49 $0.00
Disclosure

SEC source: 0001035267-23-000207 · edgardoc.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 722

Underlying: Common Stock · 722 shares

Expires 2030-11-09

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.

Read SEC document
October 26, 2023 Filed Oct 26, 2023 23:51 UTC
GUTHART GARY SDirector · CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 33,750 $0.00 Strike: $49.34 $0.00
Disclosure

SEC source: 0001035267-23-000200 · edgardoc.xml · derivative · entry 6

GUTHART GARY S · CIK 0001280628 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,750 shares

Expires 2024-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
October 26, 2023 Filed Oct 26, 2023 23:51 UTC
GUTHART GARY SDirector · CEO
SaleCommon Stock 27,385 $260.11 $7,123,030.20
Disclosure

SEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 2

GUTHART GARY S · CIK 0001280628 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,551

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $256.16 to $264.24 as follows: 2,409 shares sold at $256.16 to $257.16; 3,572 shares sold at $257.17 to $258.02; 3,090 shares sold at $258.24 to $258.97; 9,133 shares sold at $259.72 to $260.69; 4,304 shares sold at $260.75 to $261.53; 2,750 shares sold at $261.93 to $262.55 and 2,127 shares sold at $264.24. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 26, 2023 Filed Oct 26, 2023 23:51 UTC
GUTHART GARY SDirector · CEO
Exercise / conversionCommon Stock 33,750 $49.34 $1,665,336.38
Disclosure

SEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 1

GUTHART GARY S · CIK 0001280628 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 564 $0.00 Strike: $208.90 $0.00
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 9

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,451

Underlying: Common Stock · 564 shares

Expires 2029-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 273 $0.00 Strike: $179.70 $0.00
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 8

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 633

Underlying: Common Stock · 273 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 273 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · derivative · entry 7

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453

Underlying: Common Stock · 273 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 564 $275.00 $155,100.00
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,259

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 564 $208.90 $117,819.60
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 273 $271.93 $74,236.89
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,259

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 273 $177.99 $48,590.37
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 273 $271.93 $74,236.89
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,259

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 25, 2023 20:30 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 273 $179.70 $49,058.10
Disclosure

SEC source: 0001035267-23-000198 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Read SEC document
October 24, 2023 Filed Oct 26, 2023 23:51 UTC
GUTHART GARY SDirector · CEO
SaleCommon Stock 2,480 $271.93 $674,386.40
Disclosure

SEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 4

GUTHART GARY S · CIK 0001280628 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust FBO Son

Disclosed balance after: 29,840

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.

Read SEC document
October 24, 2023 Filed Oct 26, 2023 23:51 UTC
GUTHART GARY SDirector · CEO
SaleCommon Stock 2,480 $271.93 $674,386.40
Disclosure

SEC source: 0001035267-23-000200 · edgardoc.xml · nonDerivative · entry 3

GUTHART GARY S · CIK 0001280628 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust FBO Daughte

Disclosed balance after: 29,840

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 21:18 UTC
LOEB GARYGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 2,613 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-23-000189 · edgardoc.xml · derivative · entry 3

LOEB GARY · CIK 0001561733 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,837

Underlying: Common Stock · 2,613 shares

Expires 2026-10-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 21:18 UTC
LOEB GARYGeneral Counsel
Tax withholdingCommon Stock 904 $297.83 $269,238.32
Disclosure

SEC source: 0001035267-23-000189 · edgardoc.xml · nonDerivative · entry 2

LOEB GARY · CIK 0001561733 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,709

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
October 10, 2023 Filed Oct 12, 2023 21:18 UTC
LOEB GARYGeneral Counsel
Exercise / conversionCommon Stock 2,613 $0.00 $0.00
Disclosure

SEC source: 0001035267-23-000189 · edgardoc.xml · nonDerivative · entry 1

LOEB GARY · CIK 0001561733 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
September 14, 2023 Filed Sep 15, 2023 20:39 UTC
Ladd Amy LDirector
SaleCommon Stock 500 $305.68 $152,840.00
Disclosure

SEC source: 0001035267-23-000186 · edgardoc.xml · nonDerivative · entry 1

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 702

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 14, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.